05:00 PM EDT, 06/13/2024 (MT Newswires) -- Stoke Therapeutics ( STOK ) late Thursday filed a registration statement with the US Securities and Exchange Commission covering the potential sale of about 10.8 million shares from time to time by its selling shareholders.

The company said it will not receive any proceeds from the sale.

Shares of the company were down about 4.3% in recent after-hours activity.

Price: 16.77, Change: -0.75, Percent Change: -4.28